|

 









|
Research
Articles Archived
Articles
Comprehensive
review of the many
benefits of fish oils
Fish Oils: The Essential Nutrients
by
Hans R. Larsen, MSc ChE
OILOFPISCES.COM
INTERNATIONAL HEALTH
NEWS
There
are good fats and there are bad fats. Artificially produced
trans-fatty acids are bad in any amount and saturated
fats from animal products should be kept to a minimum. The
best fats or oils rather, since they are liquid at room temperature,
are those that contain the essential fatty acids so
named because without them we die. Essential fatty acids are
polyunsaturated and grouped into two families, the omega-6
EFAs and the omega-3 EFAs.
Seemingly
minor differences in their molecular structure make the two
EFA families act very differently in the body. While the metabolic
products of omega-6 acids promote inflammation, blood clotting,
and tumor growth, the omega-3 acids act entirely opposite.
Although we do need both omega-3s and omega-6s it is becoming
increasingly clear that an excess of omega-6 fatty acids can
have dire consequences. Many scientists believe that a major
reason for the high incidence of heart disease, hypertension,
diabetes, obesity, premature aging, and some forms of cancer
is the profound imbalance between our intake of omega-6 and
omega-3 fatty acids. Our ancestors evolved on a diet with
a ratio of omega-6 to omega-3 of about 1:1. A massive change
in dietary habits over the last few centuries has changed
this ratio to something closer to 20:1 and this spells trouble.
[1-3]
Sources
and requirements
The main sources of omega-6 fatty acids are vegetable oils
such as corn oil and soy oil which contain a high proportion
of linoleic acid. Omega-3 acids are found in flaxseed oil,
walnut oil, and marine plankton and fatty fish. The main component
of flaxseed and walnut oils is alpha-linolenic acid while
the predominant fatty acids found in fatty fish and fish oils
are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
The most beneficial and active of these fatty acids are EPA
and DHA. Alpha-linolenic acid can be converted to EPA and
DHA in the body, but the conversion is quite inefficient especially
in older people. [1, 2]
Scientists
were first alerted to the many benefits of EPA and DHA in
the early 1970s when Danish physicians observed that Greenland
Eskimos had an exceptionally low incidence of heart disease
and arthritis despite the fact that they consumed a high-fat
diet. Intensive research soon discovered that two of the fats
(oils) they consumed in large quantities, EPA and DHA, were
actually highly beneficial. More recent research has established
that fish oils (EPA and DHA) play a crucial role in the prevention
of atherosclerosis, heart attack, depression, and cancer.
Clinical trials have shown that fish oil supplementation is
effective in the treatment of many disorders including rheumatoid
arthritis, diabetes, ulcerative colitis, and Raynaud's disease.
[1-5]
Recognizing
the unique benefits of EPA and DHA and the serious consequences
of a deficiency the US National Institutes of Health recently
published Recommended Daily Intakes of fatty acids. They recommend
a total daily intake of 650 mg of EPA and DHA, 2.22 g/day
of alpha-linolenic acid and 4.44 g/day of linoleic acid. Saturated
fat intake should not exceed 8 per cent of total calorie intake
or about 18 g/day.
Good
for the brain and children too
The human brain is one of the largest "consumers"
of DHA. A normal adult human brain contains more than 20 grams
of DHA. Low DHA levels have been linked to low brain serotonin
levels which again are connected to an increased tendency
to depression, suicide, and violence. A high intake of fish
has been linked to a significant decrease in age-related memory
loss and cognitive function impairment and a lower risk of
developing Alzheimer's disease. A recent study found that
Alzheimer's patients given an omega-3-rich supplement experienced
a significant improvement in their quality of life.[6-9]
Several
studies have established a clear association between low levels
of omega-3 fatty acids and depression. Other studies have
shown that countries with a high level of fish consumption
have fewer cases of depression. Researchers at Harvard Medical
School have successfully used fish oil supplementation to
treat bipolar disorder (manic- depressive illness) and British
researchers report encouraging results in the treatment of
schizophrenia. [10-15]
An
adequate intake of DHA and EPA is particularly important during
pregnancy and lactation. During this time the mother must
supply all the baby's needs for DHA and EPA because it is
unable to synthesize these essential fatty acids itself. DHA
makes up 15 to 20% of the cerebral cortex and 30 to 60% of
the retina so it is absolutely necessary for normal development
of the fetus and baby. There is some evidence that an insufficient
intake of omega-3 fatty acids may increase the risk of premature
birth and an abnormally low birth weight. There is also emerging
evidence that low levels of omega-3 acids are associated with
hyperactivity in children. [1, 3, 16-22]
The
constant drain on a mother's DHA reserves can easily lead
to a deficiency and some researchers believe that preeclampsia
(pregnancy- related high blood pressure) and postpartum depression
could be linked to a DHA deficiency. Experts recommend that
women get at least 500- 600 mg of DHA every day during pregnancy
and lactation. The easiest way to ensure this intake is to
take a good fish oil supplement daily. [17-19]
Researchers
at the University of Sydney have found that children who regularly
eat fresh, oily fish have a four times lower risk of developing
asthma than do children who rarely eat such fish. They speculate
that EPA present in the fish may prevent the development of
asthma or reduce its severity by reducing airway inflammation
and responsiveness. Researchers at the University of Wyoming
have found that supplementation with 3.3 grams/day of fish
oil markedly reduces breathing difficulties and other symptoms
in asthma patients. Other research has found fish oil to be
beneficial in the treatment of other lung diseases such as
cystic fibrosis and emphysema. [23-29]
The
heart's best friend
An enormous amount of medical literature testifies to the
fact that fish oils prevent and may help to ameliorate or
reverse atherosclerosis, angina, heart attack, congestive
heart failure, arrhythmias, stroke, and peripheral vascular
disease. Fish oils help maintain the elasticity of artery
walls, prevent blood clotting, reduce blood pressure and stabilize
heart rhythm. [1-4, 30-33]
Danish
researchers have concluded that fish oil supplementation may
help prevent arrhythmias and sudden cardiac death in healthy
men. An Italian study of 11,000 heart attack survivors found
that patients supplementing with fish oils markedly reduced
their risk of another heart attack, a stroke or death. A group
of German researchers found that fish oil supplementation
for 2 years caused regression of atherosclerotic deposits
and American medical researchers report that men who consume
fish once or more every week have a 50% lower risk of dying
from a sudden cardiac event than do men who eat fish less
than once a month. [34-40]
Greek
researchers report that fish oil supplementation (10 grams/day)
reduces the number of attacks by 41% in men suffering from
angina. Norwegian medical doctors have found that fish oil
supplementation reduces the severity of a heart attack and
Indian researchers report that supplementation started immediately
after a heart attack reduces future complications. Bypass
surgery and angioplasty patients reportedly also benefit from
fish oils and clinical trials have shown that fish oils are
safe for heart disease patients. The evidence is indeed overwhelming.
An adequate daily intake (about 1 gram) of EPA and DHA is
essential to maintain a healthy heart. Fish oils are especially
important for diabetics who have an increased risk of heart
disease. [41-49]
Researchers
at the University of Cincinnati have found that supplementing
with as little as 2 grams/day of fish oil (410 mg of EPA plus
285 mg of DHA) can lower diastolic pressure by 4.4 mm Hg and
systolic pressure by 6.5 mm Hg in people with elevated blood
pressure. Enough to avoid taking drugs in cases of borderline
hypertension. Several other clinical trials have confirmed
that fish oils are indeed effective in lowering high blood
pressure and that they may work even better if combined with
a program of salt restriction. [50-55]
Reduces
pain and helps prevent cancer
Fish oils are particularly effective in reducing inflammation
and can be of great benefit to people suffering from rheumatoid
arthritis or ulcerative colitis. Daily supplementation with
as little as 2.7 grams of EPA and 1.8 grams of DHA can markedly
reduce the number of tender joints and increase the time before
fatigue sets in. Some studies have also noted a decrease in
morning stiffness and at least two clinical trials concluded
that arthritis patients who took fish oils could eliminate
or sharply reduce their use of NSAIDs and other arthritis
drugs. [56-61]
Patients
with ulcerative colitis have abnormally low blood levels of
EPA. Clinical trials have shown that supplementation with
fish oil (2.7 grams of EPA and 1.8 grams of DHA daily) can
reduce the severity of the condition by more than 50% and
enable many patients to discontinue anti-inflammatory medication
and steroids. [62-64]
There
is now also considerable evidence that fish oil consumption
can delay or reduce tumor development in breast cancer. Studies
have also shown that a high blood level of omega-3 fatty acids
combined with a low level of omega-6 acids reduces the risk
of developing breast cancer. Daily supplementation with as
little as 2.5 grams of fish oils has been found effective
in preventing the progression from benign polyps to colon
cancer and Korean researchers recently reported that prostate
cancer patients have low blood levels of omega-3 fatty acids.
Greek researchers report that fish oil supplementation improves
survival and quality of life in terminally ill cancer patients.
[65-73]
Safe
and easily available
It is estimated that 85% or more of people in the Western
world are deficient in omega-3 fatty acids and most get far
too much of the omega-6 fatty acids. Vegetarian diets, for
example, tend to be very high in omega-6.
The
recommended daily intake of EPA plus DHA is about 650 mg rising
to 1000 mg/day during pregnancy and lactation. Clinical trials
have used anywhere from 1 g/day to 10 g/day, but little additional
benefit has been observed at levels above 5 g/day of EPA and
DHA combined. The benefits of therapeutic supplementation
may become evident in a few weeks when blood parameters (triglycerides,
fibrinogen) are involved, but may take 3 months or longer
to materialize in degenerative diseases like atherosclerosis
and rheumatoid arthritis. [74, 75]
The
processing and packaging of the fish oil are crucial in determining
its quality. Low quality oils may be quite unstable and contain
significant amounts of mercury, pesticides, and undesirable
oxidation products. High quality oils are stabilized with
adequate amounts of vitamin E and are packaged in individual
foil pouches or other packaging impervious to light and oxygen.
Some very recent research carried out at the University of
Minnesota found that emulsified fish oils are much better
absorbed than the straight oils in gelatin capsules. [76]
Cod
liver oils and fish oils are not the same. Cod liver oil is
extracted from cod liver and is an excellent source
of vitamins A and D. Fish oils are extracted from the tissues
(flesh) of fatty fish like salmon and herring and are good
sources of EPA and DHA. Fish oils contain very little vitamin
A and D, but cod liver oil does contain EPA and DHA. However,
you would probably exceed the recommended daily intake of
vitamins A and D if you were to try to obtain therapeutic
amounts of EPA and DHA from cod liver oil.
Supplementing
with fish oils has been found to be entirely safe even for
periods as long as 7 years and no significant adverse effects
have been reported in hundreds of clinical trials using as
much as 18 grams/day of fish oils. Fish oil supplementation
does, however, lower blood concentrations of vitamin E so
it is a good idea to take extra vitamin E when adding fish
oils to your diet. A clinical trial carried out by the US
Department of Agriculture found that taking 200 mg/day of
synthetic vitamin E (equivalent to about 100 IU of natural
alpha- tocopherol) is sufficient to completely counteract
this effect of fish oil supplementation. [74,
75, 77, 78]
Click
here for more information on Omega 3 Essential Nutrients
REFERENCES
-
Simopoulos, Artemis. Omega-3 fatty acids in health and disease
and in growth and development. American Journal of Clinical
Nutrition, Vol. 54, 1991, pp. 438-63
-
Pepping, Joseph. Omega-3 essential fatty acids. American Journal
of Health-System Pharmacy, Vol. 56, April 15, 1999, pp. 719-24
-
Uauy-Dagach,
Ricardo and Valenzuela, Alfonso. Marine oils: the health benefits
of n-3 fatty acids. Nutrition Reviews, Vol. 54, November 1996,
pp. S102-S108
-
Connor, William E. Importance of n-3 fatty acids in health and
disease. American Journal of Clinical Nutrition, Vol. 71 (suppl),
January 2000, pp. 171S-75S
-
DiGiacomo,
Ralph A. , et al. Fish-oil Dietary Supplementation in Patients
with Raynaud's Phenomenon: A Double-Blind, Controlled, Prospective
Study. The American Journal of Medicine, Vol. 86, February 1989,
pp. 158-164
-
Levine, Barbara S. Most frequently asked questions about DHA.
Nutrition Today, Vol. 32, November/December 1997, pp. 248-49
-
Kalmijn, S., et al. Polyunsaturated fatty acids, antioxidants,
and cognitive function in very old men. American Journal of
Epidemiology, Vol. 145, January 1, 1997, pp. 33-41
-
Kalmijn,
S., et al. Dietary fat intake and the risk of incident dementia
in the Rotterdam Study. Annals of Neurology, Vol. 42(5), November
1997, pp. 776-82
-
Yehuda,
S., et al. Essential fatty acids preparation (SR-3) improves
Alzheimer's patients quality of life. International Journal
of Neuroscience, Vol. 87(3-4), November 1996, pp. 141-9
-
Edwards,
R., et al. Omega-3 polyunsaturated fatty acid levels in the
diet and in red blood cell membranes of depressed patients.
Journal of Affective Disorders, Vol. 48, March 1998, pp. 149-55
-
Hibbeln, Joseph R. Fish consumption and major depression. The
Lancet, Vol. 351, April 18, 1998, p. 1213 (correspondence)
-
Hibbeln,
Joseph R. and Salem, Norman. Dietary polyunsaturated fatty acids
and depression: when cholesterol does not satisfy. American
Journal of Clinical Nutrition, Vol. 62, July 1995, pp. 1-9
-
Stoll, Andrew L., et al. Omega 3 fatty acids in bipolar disorder.
Archives of General Psychiatry, Vol. 56, May 1999, pp. 407-12
and pp. 415-16 (commentary)
-
Calabrese, Joseph R., et al. Fish oils and bipolar disorder.
Archives of General Psychiatry, Vol. 56, May 1999, pp. 413-14
(commentary)
-
Laugharne,
J.D.E., et al. Fatty acids and schizophrenia. Lipids, Vol. 31
(suppl), 1996, pp. S163-S65
-
Jensen, Craig L., et al. Effect of docosahexaenoic acid supplementation
of lactating women on the fatty acid composition of breast milk
lipids and maternal and infant plasma phospholipids. American
Journal of Clinical Nutrition, Vol. 71 (suppl), January 2000,
pp. 292S-99S
-
Makrides,
Maria and Gibson, Robert A. Long-chain polyunsaturated fatty
acid requirements during pregnancy and lactation. American Journal
of Clinical Nutrition, Vol. 71 (suppl), 2000, pp. 307S-11S
-
Connor,
William E., et al. Increased docosahexaenoic acid levels in
human newborn infants by administration of sardines and fish
oil during pregnancy. Lipids, Vol. 31 (suppl), 1996, pp. S183-S87
-
Cunnane, S.C., et al. Breast-fed infants achieve a higher rate
of brain and whole body docosahexaenoate accumulation than formula-fed
infants not consuming dietary docosahexaenoate. Lipids, Vol.
35, January 2000, pp. 105-11
-
Carlson,
S.E., et al. Long-chain polyunsaturated fatty acids and development
of human infants. Acta Paediatr Suppl, Vol. 88 (430), August
1999, pp. 72-7
-
Mitchell,
E.A., et al. Clinical characteristics and serum essential fatty
acid levels in hyperactive children. Clin Pediatr (Phila), Vol.
26, August 1987, pp. 406-11
-
Stevens,
Laura J., et al. Essential fatty acid metabolism in boys with
attention-deficit hyperactivity disorder. American Journal of
Clinical Nutrition, Vol. 62, No. 4, October 1995, pp. 761-68
-
Hodge,
Linda, et al. Consumption of oily fish and childhood asthma
risk. Medical Journal of Australia, Vol. 164, February 5, 1996,
pp. 137-40
-
Broughton,
K. Shane, et al. Reduced asthma symptoms with n-3 fatty acid
ingestion are related to 5-series leukotriene production. American
Journal of Clinical Nutrition, Vol. 65, April 1997, pp. 1011-17
-
Dry,
J. and Vincent, D. Effect of a fish oil diet on asthma: results
of a 1-year double-blind study. International Archives of Allergy
and Applied Immunology, Vol. 95, No. 2/3, 1991, pp. 156-7
-
Shahar,
Eyal, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related
chronic obstructive pulmonary disease. The New England Journal
of Medicine, Vol. 331, No. 4, July 28, 1994, pp. 228-33
-
Lawrence,
R. and Sorrell, T. Eicosapentaenoic acid in cystic fibrosis:
evidence of a pathogenetic role for leukotriene B4. The Lancet,
Vol. 342, August 21, 1993, pp. 465-69
-
Katz,
D.P., et al. The use of an intravenous fish oil emulsion enriched
with omega-3 fatty acids in patients with cystic fibrosis. Nutrition,
Vol. 12, May 1996, pp. 334-39
-
Schwartz,
Joel. Role of polyunsaturated fatty acids in lung disease. American
Journal of Clinical Nutrition, Vol. 71 (suppl), January 2000,
pp. 393S-96S
-
Daviglus,
Martha L., et al. Fish consumption and the 30-year risk of fatal
myocardial infarction. New England Journal of Medicine, Vol.
336, April 10, 1997, pp. 1046-53
-
Christensen,
Jeppe Hagstrup, et al. Effect of fish oil on heart rate variability
in survivors of myocardial infarction. British Medical Journal,
Vol. 312, March 16, 1996, pp. 677-78
-
Simon,
Joel A., et al. Serum fatty acids and the risk of coronary heart
disease. American Journal of Epidemiology, Vol. 142, No. 5,
September 1, 1995, pp. 469-76
-
Flaten,
Hugo, et al. Fish-oil concentrate: effects of variables related
to cardiovascular disease. American Journal of Clinical Nutrition,
Vol. 52, 1990, pp. 300-06
-
Christensen,
Jeppe Hagstrup, et al. Heart rate variability and fatty acid
content of blood cell membranes: a dose-response study with
n-3 fatty acids. American Journal of Clinical Nutrition, Vol.
70, September 1999, pp. 331-37
-
Dietary
supplementation with n-3 polyunsaturated fatty acids and vitamin
E after myocardial infarction: results of the GISSI- Prevenzione
trial. The Lancet, Vol. 354, August 7, 1999, pp. 447-55
-
Brown,
Morris. Do vitamin E and fish oil protect against ischaemic
heart disease? The Lancet, Vol. 354, August 7, 1999, pp. 441-42
(commentary)
-
von Schacky, Clemens, et al. The effect of dietary omega-3 fatty
acids on coronary atherosclerosis. Annals of Internal Medicine,
Vol. 130, April 6, 1999, pp. 554-62
-
Albert,
Christine M., et al. Fish consumption and risk of sudden cardiac
death. Journal of the American Medical Association, Vol. 279,
January 7, 1998, pp. 23-28
-
Kromhout,
Daan. Fish consumption and sudden cardiac death. Journal of
the American Medical Association, Vol. 279, January 7, 1998,
pp. 65-66 (editorial)
-
Siscovick,
David S., et al. Dietary intake and cell membrane levels of
long-chain n-3 polyunsaturated fatty acids and the risk of primary
cardiac arrest. Journal of the American Medical Association,
Vol. 274, No. 17, November 1, 1995, pp. 1363-67
-
Salachas,
A., et al. Effects of low-dose fish oil concentrate on angina,
exercise tolerance time, serum triglycerides, and platelet function.
Angiology, Vol. 45, December 1994, pp. 1023-31
-
Landmark,
K., et al. Use of fish oils appears to reduce infarct size as
estimated from peak creatine kinase and lactate dehydrogenase
activities. Cardiology, Vol. 89 (2), 1998, pp. 94-102
-
Singh,
R.B., et al. Randomized, double-blind, placebo-controlled trial
of fish oil and mustard oil in patients with suspected acute
myocardial infarction. Cardiovasc Drugs Ther, Vol. 11, July
1997, pp. 485-91
-
Eritsland,
J., et al. Long-term effects of n-3 polyunsaturated fatty acids
on haemostatic variables and bleeding episodes in patients with
coronary artery disease. Blood Coagul Fibrinolysis, Vol. 6,
February 1995, pp. 17-22
-
von
Schacky, Clemens. n-3 fatty acids and the prevention of coronary
atherosclerosis. American Journal of Clinical Nutrition, Vol.
71 (suppl), January 2000, pp. S224-27S
-
Connor,
William E. Diabetes, fish oil, and vascular disease. Annals
of Internal Medicine, Vol. 123, No. 12, December 15, 1995, pp.
950-52
-
McManus,
Ruth M., et al. A comparison of the effects of n-3 fatty acids
from linseed oil and fish oil in well-controlled type II diabetes.
Diabetes Care, Vol. 19, May 1996, pp. 463-67
-
Luo,
Jing, et al. Moderate intake of n-3 fatty acids for 2 months
has no detrimental effect on glucose metabolism and could ameliorate
the lipid profile in type 2 diabetic men. Diabetes Care, Vol.
21, May 1998, pp. 717-24
-
Rivellese, Angela A., et al. Long-term effects of fish oil on
insulin resistance and plasma lipoproteins in NIDDM patients
with hypertriglyceridemia. Diabetes Care, Vol. 19, November
1996, pp. 1207-13
-
Appel,
Lawrence J., et al. Does supplementation of diet with "fish
oil" reduce blood pressure? Archives of Internal Medicine,
Vol. 153, June 28, 1993, pp. 1429-38
-
Radack,
Kenneth, et al. The effects of low doses of n-3 fatty acid supplementation
on blood pressure in hypertensive subjects. Archives of Internal
Medicine, Vol. 151, June 1991, pp. 1173-80
-
Morris,
Martha Clare, et al. Does fish oil lower blood pressure? A meta-analysis
of controlled trials. Circulation, Vol. 88, No. 2, August 1993,
pp. 523-33
-
Andreassen,
A.K., et al. Hypertension prophylaxis with omega-3 fatty acids
in heart transplant recipients. J Am Coll Cardiol, Vol. 29,
May 1997, pp. 1324-31
-
Cobiac,
L., et al. Effects of dietary sodium restriction and fish oil
supplements on blood pressure in the elderly. Clin Exp Pharmacol
Physiol, Vol. 18, May 1991, pp. 265-68
-
Toft,
Ingrid, et al. Effects of n-3 polyunsaturated fatty acids on
glucose homeostasis and blood pressure in essential hypertension.
Annals of Internal Medicine, Vol. 123, No. 12, December 15,
1995, pp. 911-18
-
Kremer,
Joel M., et al. Fish-oil fatty acid supplementation in active
rheumatoid arthritis: A double-blinded, controlled, crossover
study. Annals of Internal Medicine, Vol. 106, April 1987, pp.
497- 503
-
Kremer,
Joel M. n-3 fatty acid supplements in rheumatoid arthritis.
American Journal of Clinical Nutrition, Vol. 71 (suppl), January
2000, pp. 349S-51S
-
Fortin,
Paul R., et al. Validation of a meta-analysis: the effects of
fish oil in rheumatoid arthritis. Journal of Clinical Epidemiology,
Vol. 48, 1995, pp. 1379-90
-
Kremer,
J.M., et al. Effects of high-dose fish oil on rheumatoid arthritis
after stopping nonsteroidal anti-inflammatory drugs - clinical
and immune correlates. Arthritis and Rheumatology, Vol. 38,
August 1995, pp. 1107-14
-
Geusens,
P., et al. Long-term effect of omega-3 fatty acid supplementation
in active rheumatoid arthritis: a 12-month, double- blind, controlled
study. Arthritis and Rheumatology, Vol. 37, June 1994, pp. 824-29
-
Navarro,
Elisabet, et al. Abnormal fatty acid pattern in rheumatoid arthritis
- A rationale for treatment with marine and botanical lipids.
Journal of Rheumatology, Vol. 27, February 2000, pp. 298-303
-
Aslan,
Alex and Triadafilopoulos, George. Fish oil fatty acid supplementation
in active ulcerative colitis: A double-blind, placebo-controlled,
crossover study. American Journal of Gastroenterology, Vol.
87, April 1992, pp. 432-37
-
Salomon,
P., et al. Treatment of ulcerative colitis with fish oil n-3
omega fatty acid: an open trial. Journal of Clinical Gastroenterology,
Vol. 12, April 1990, pp. 157-61
-
Siguel, E.N. and Lerman, R.H. Prevalence of essential fatty
acid deficiency in patients with chronic gastrointestinal disorders.
Metabolism, Vol. 45, January 1996, pp. 12-23
-
Simonsen, Neal, et al. Adipose tissue omega-3 and omega-6 fatty
acid content and breast cancer in the EURAMIC Study. American
Journal of Epidemiology, Vol. 147, No. 4, 1998, pp. 342-52
-
Cave,
W.T. Jr. Dietary omega-3 polyunsaturated fats and breast cancer.
Nutrition, Vol. 12 (suppl), January 1996, pp. S39-42
-
Fernandez-Banares,
F., et al. Changes of the mucosal n3 and n6 fatty acid status
occur early in the colorectal adenoma-carcinoma sequence. Gut,
Vol. 38, 1996, pp. 254-59
-
Anti,
M., et al. Effects of different doses of fish oil on rectal
cell proliferation in patients with sporadic colonic adenomas.
Gastroenterology, Vol. 107, December 1994, pp. 1709-18
-
Yang,
Y.J., et al. Comparison of fatty acid profiles in the serum
of patients with prostate cancer and benign prostatic hyperplasia.
Clinical Biochemistry, Vol. 32, August 1999, pp. 405-09
-
Norrish,
A.E., et al. Prostate cancer risk and consumption of fish oils:
a dietary biomarker-based case-control study. British Journal
of Cancer, Vol. 81, No. 7, December 1999, pp. 1238-42
-
Gogos,
Charalambos A., et al. Dietary omega-3 polyunsaturated fatty
acids plus vitamin E restore immunodeficiency and prolong survival
for severely ill patients with generalized malignancy. Cancer,
Vol. 82, January 15, 1998, pp. 395-402
-
Wigmore,
S.J., et al. The effect of polyunsaturated fatty acids on the
progress of cachexia in patients with pancreatic cancer. Nutrition,
Vol. 12 (suppl), January 1996, pp. S27-30
-
Barber,
M.D., et al. The effect of an oral nutritional supplement enriched
with fish oil on weight-loss in patients with pancreatic cancer.
British Journal of Cancer, Vol. 81, No. 1, September 1999, pp.
80-86
-
Saynor,
R. and Gillott, T. Changes in blood lipids and fibrinogen with
a note on safety in a long term study on the effects of n-3
fatty acids in subjects receiving fish oil supplements and followed
for seven years. Lipids, Vol. 27, July 1992, pp. 533-38
-
Eritsland,
Jan. Safety considerations of polyunsaturated fatty acids. American
Journal of Clinical Nutrition, Vol. 71 (suppl), January 2000,
pp. 197S-201S
-
Bibus,
Douglas M., et al. Bioavailability Studies of Emulsified Flavored
Fish Oil. The University of Minnesota, Austin, MN. January 21,
2000
-
Nair,
Padmanabhan P., et al. Dietary fish oil-induced changes in the
distribution of alpha-tocopherol, retinol, and beta-carotene
in plasma, red blood cells, and platelets: modulation by vitamin
E. American Journal of Clinical Nutrition, Vol. 58, July 1993,
pp. 98- 102
-
Sanders,
T.A.B. and Hinds, Allison. The influence of a fish oil high
in docosahexaenoic acid on plasma lipoprotein and vitamin E
concentrations and haemostatic function in healthy male volunteers.
British Journal of Nutrition, Vol 68, July 1992, pp. 163-73
|
|